In June 2025, the European Medicines Agency recommended that product information for semaglutide medicines be updated to include NAION as a very rare side effect
The broader health impacts of GLP-1s are just beginning to be felt, showing incredible promise in improving metabolic health and even treating addiction
( 18 ) study may be the type of exercise performed, where the low-intensity cycling was not strenuous enough to induce a change in LM as observed in the present study 13-week running programme
It was reported that 83% of these patients have an established cardiovascular disease, kidney disease (CKD), or both
Treatment effectiveness outcomes incorporated changes observed in weight measurements, metabolic parameters, and cardiovascular health indicators monitored during the course [15]
May your injection sites stay healthy, your rotation stay consistent, and your weight loss stay steady.